JP2020022446A - Drinking composition - Google Patents
Drinking composition Download PDFInfo
- Publication number
- JP2020022446A JP2020022446A JP2019139513A JP2019139513A JP2020022446A JP 2020022446 A JP2020022446 A JP 2020022446A JP 2019139513 A JP2019139513 A JP 2019139513A JP 2019139513 A JP2019139513 A JP 2019139513A JP 2020022446 A JP2020022446 A JP 2020022446A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- vanillyl
- alkyl ether
- vitamin
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 230000035622 drinking Effects 0.000 title claims abstract description 27
- 150000005215 alkyl ethers Chemical class 0.000 claims abstract description 36
- -1 polyoxyethylene Polymers 0.000 claims abstract description 29
- KOCVACNWDMSLBM-UHFFFAOYSA-N 4-(Ethoxymethyl)-2-methoxyphenol Chemical compound CCOCC1=CC=C(O)C(OC)=C1 KOCVACNWDMSLBM-UHFFFAOYSA-N 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 241000234314 Zingiber Species 0.000 claims abstract description 19
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 19
- 235000008397 ginger Nutrition 0.000 claims abstract description 19
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 15
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 14
- 229960002477 riboflavin Drugs 0.000 claims abstract description 14
- 229960003495 thiamine Drugs 0.000 claims abstract description 14
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 14
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 13
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 13
- 229930195729 fatty acid Natural products 0.000 claims abstract description 13
- 239000000194 fatty acid Substances 0.000 claims abstract description 13
- 229940078465 vanillyl butyl ether Drugs 0.000 claims abstract description 13
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 13
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 13
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 13
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 13
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 claims description 15
- 239000004359 castor oil Substances 0.000 claims description 14
- 235000019438 castor oil Nutrition 0.000 claims description 14
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 14
- 235000008434 ginseng Nutrition 0.000 claims description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 7
- 241000208340 Araliaceae Species 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 abstract description 17
- 235000019634 flavors Nutrition 0.000 abstract description 17
- 244000000626 Daucus carota Species 0.000 abstract description 8
- 235000002767 Daucus carota Nutrition 0.000 abstract description 8
- 235000004443 Ricinus communis Nutrition 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 48
- 235000019640 taste Nutrition 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- 240000004371 Panax ginseng Species 0.000 description 11
- 235000019633 pungent taste Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229950001574 riboflavin phosphate Drugs 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical class COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WOKDXPHSIQRTJF-UHFFFAOYSA-N 3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO WOKDXPHSIQRTJF-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- DNZGTMUOLYMUKJ-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCC(O)=O DNZGTMUOLYMUKJ-UHFFFAOYSA-N 0.000 description 1
- MMQZBEXYFLXHEN-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O MMQZBEXYFLXHEN-UHFFFAOYSA-N 0.000 description 1
- WTAYIFXKJBMZLY-XZABIIKCSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O WTAYIFXKJBMZLY-XZABIIKCSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- SELHWUUCTWVZOV-UHFFFAOYSA-N dodecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCC(O)=O SELHWUUCTWVZOV-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100688 oral solution Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
Abstract
Description
本発明は、バニリルアルコール誘導体を含有する飲用組成物に関するものであり、医薬、食品の分野に応用できるものである。 The present invention relates to a drinking composition containing a vanillyl alcohol derivative, and can be applied to the fields of medicine and food.
バニリルエチルエーテル、バニリルブチルエーテル等のバニリルアルキルエーテルは、温感を与える物質として知られている(特許文献1、2)。従って、バニリルエチルエーテル又はバニリルブチルエーテルは、香料、歯磨組成物、化粧料、外用剤として用いられる。一方、バニリルアルコール誘導体自身の極めて強い辛味、苦味、雑味があり、風味上の問題点がある。 Vanillyl alkyl ethers such as vanillyl ethyl ether and vanillyl butyl ether are known as substances giving a warm feeling (Patent Documents 1 and 2). Therefore, vanillyl ethyl ether or vanillyl butyl ether is used as a fragrance, a dentifrice composition, a cosmetic, or an external preparation. On the other hand, the vanillyl alcohol derivative itself has extremely strong pungency, bitterness, and unpleasant taste, and has a problem in flavor.
本発明者らは、バニリルエチルエーテル又はバニリルブチルエーテルを含有した飲用組成物は、極めて強い辛味、苦味、雑味などの風味に課題があるという知見を得た。さらに、本発明者らによると、生姜又は人参共存下において、バニリルアルキルエーテルの風味が、より増悪するという知見を得、飲食品に供する際に課題があることが判明した。 The present inventors have found that a drinking composition containing vanillyl ethyl ether or vanillyl butyl ether has a problem in flavors such as extremely strong pungency, bitterness, and unpleasant taste. Furthermore, according to the present inventors, it has been found that the flavor of vanillyl alkyl ether worsens in the coexistence of ginger or ginseng.
したがって、本発明は、生姜又は人参共存下における、飲用組成物中のバニリルアルキルエーテルの風味を改善した飲用組成物を提供することを目的とする。 Therefore, an object of the present invention is to provide a drinking composition in which the flavor of vanillyl alkyl ether in the drinking composition is improved in the presence of ginger or ginseng.
本発明者らは、上記課題を解決すべく鋭意検討した結果、ビタミンB1又はその誘導体又はその塩、ビタミンB2又はその誘導体又はその塩、ポリオキシエチレン硬化ヒマシ油、及びポリグリセリン脂肪酸エステルからなる群より選ばれる1種以上を含有させた場合に、バニリルエチルエーテル又はバニリルブチルエーテルの風味が改善されることを見出し、本発明を完成した。 The present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, a group consisting of vitamin B1 or a derivative thereof or a salt thereof, vitamin B2 or a derivative thereof or a salt thereof, polyoxyethylene hydrogenated castor oil, and polyglycerin fatty acid ester It has been found that the flavor of vanillyl ethyl ether or vanillyl butyl ether is improved when one or more selected from the group is contained, and the present invention has been completed.
即ち本発明は、
(1)a)バニリルエチルエーテル又はバニリルブチルエーテルから選ばれる少なくとも1種のバニリルアルキルエーテル、
b)生姜又は人参から選ばれる少なくとも1種、及び
c)ビタミンB1若しくはその誘導体又はその塩、ビタミンB2若しくはその誘導体又はその塩、ポリオキシエチレン硬化ヒマシ油、及びポリグリセリン脂肪酸エステルからなる群より選ばれる少なくとも1種
を含有する飲用組成物、
(2)バニリルアルキルエーテル1質量部に対して、
b)生姜又は人参から選ばれる少なくとも1種が原料乾燥物換算量で16〜10000質量部であることを特徴とする請求項1に記載の飲用組成物、
(3)a)バニリルアルキルエーテル1質量部に対して、
c)ビタミンB1若しくはその誘導体又はその塩が0.1〜30質量部であることを特徴とする請求項1に記載の飲用組成物、
(4)a)バニリルアルキルエーテル1質量部に対して、
c)ビタミンB2若しくはその誘導体又はその塩が0.1〜50質量部であることを特徴とする請求項1に記載の飲用組成物、
(5)a)バニリルアルキルエーテル1質量部に対して、
c)ポリオキシエチレン硬化ヒマシ油が8〜3500質量部であることを特徴とする請求項1に記載の飲用組成物、
(6)a)バニリルアルキルエーテル1質量部に対して、
c)ポリグリセリン脂肪酸エステルが8〜3500質量部であることを特徴とする請求項1に記載の飲用組成物、
である。
That is, the present invention
(1) a) at least one kind of vanillyl alkyl ether selected from vanillyl ethyl ether or vanillyl butyl ether;
b) at least one selected from ginger or ginseng; and c) selected from the group consisting of vitamin B1 or a derivative or salt thereof, vitamin B2 or a derivative or salt thereof, polyoxyethylene hydrogenated castor oil, and polyglycerin fatty acid ester. Drinking composition comprising at least one of
(2) 1 part by mass of vanillyl alkyl ether,
b) The drinking composition according to claim 1, wherein at least one selected from ginger or ginseng is 16 to 10000 parts by mass in terms of a raw material dry matter.
(3) a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) vitamin B1 or a derivative thereof or a salt thereof is 0.1 to 30 parts by mass.
(4) a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) vitamin B2 or a derivative thereof or a salt thereof is 0.1 to 50 parts by mass.
(5) a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) polyoxyethylene hydrogenated castor oil is 8 to 3500 parts by mass.
(6) a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) the polyglycerin fatty acid ester is 8 to 3500 parts by mass.
It is.
本発明により、ビタミンB1若しくはその誘導体又はその塩、ビタミンB2若しくはその誘導体又はその塩、ポリオキシエチレン硬化ヒマシ油、及びポリグリセリン脂肪酸エステルから選ばれる1種以上を含有させることで、生姜又は人参共存下における、バニリルアルキルエーテルの不快味を抑制した飲用組成物を提供することが可能になった。 According to the present invention, ginger or ginseng coexists by containing at least one selected from vitamin B1 or a derivative thereof or a salt thereof, vitamin B2 or a derivative thereof or a salt thereof, polyoxyethylene hydrogenated castor oil, and polyglycerin fatty acid ester. It has become possible to provide a drinking composition in which the unpleasant taste of vanillyl alkyl ether below is suppressed.
本発明におけるバニリルアルキルエーテルとは、バニリルエチルエーテル又はバニリルブチルエーテルであり、可食性のものであれば特に限定されない。市販品を購入することができ、例えば、シグマアルドリッチジャパン合同会社社製バニリルブチルエーテル等が挙げられる。バニリルアルキルエーテルの含有量は、特に限定されないが、温感の感じ方や風味の面から、飲用組成物全量に対し、0.0001〜0.02w/v%が好ましく、0.0008〜0.015w/v%がより好ましい。 The vanillyl alkyl ether in the present invention is vanillyl ethyl ether or vanillyl butyl ether, and is not particularly limited as long as it is edible. Commercial products can be purchased, and examples thereof include vanillyl butyl ether manufactured by Sigma-Aldrich Japan GK. The content of the vanillyl alkyl ether is not particularly limited, but is preferably 0.0001 to 0.02 w / v%, more preferably 0.0008 to 0.015 w / v%, based on the total amount of the drinking composition, in terms of feeling of warmth and flavor. More preferred.
本発明における生姜又は人参から選ばれる少なくとも1種(以下、場合により、b)成分とも言う)は、エキスの形態での配合が好ましい。エキスの製造は通常の方法、例えば、抽出溶媒を用いて、適当な温度(低温又は加熱)にて、原料から抽出する方法などにより行う。抽出溶媒は適当に選択できるが、好ましくは、水、親水性溶媒およびこれらの混合溶媒が用いられ、特に、親水性溶媒としてエタノールを用いるのが良い。本発明のエキスとは、液状抽出物をそのまま使用できるほか、水などで希釈したもの、液状抽出物の濃縮物、液状抽出物の乾固物としても使用できる。すなわち、本発明のエキスには、乾燥エキス、軟エキス、流エキス、チンキなどいずれのものも包含される。エキスは市販品を購入することもでき、例えば、松浦薬業株式会社社製ショウキョウエキス、アルプス薬品工業株式会社社製ニンジンエキス等が挙げられる。 In the present invention, at least one kind selected from ginger or ginseng (hereinafter, sometimes also referred to as component b)) is preferably added in the form of an extract. The extract is produced by a usual method, for example, a method of extracting from a raw material at an appropriate temperature (low temperature or heating) using an extraction solvent. Although an extraction solvent can be appropriately selected, water, a hydrophilic solvent and a mixed solvent thereof are preferably used, and particularly, ethanol is preferably used as the hydrophilic solvent. As the extract of the present invention, a liquid extract can be used as it is, or it can be used as diluted with water or the like, a concentrated liquid extract, or a dried liquid extract. That is, the extract of the present invention includes any of dry extract, soft extract, fluid extract, tincture and the like. As the extract, a commercially available product can be purchased, and examples thereof include a ginger extract manufactured by Matsuura Pharmaceutical Co., Ltd. and a carrot extract manufactured by Alps Pharmaceutical Co., Ltd.
b)成分の含有量は、特に限定されないが、バニリルアルキルエーテルの風味改善の面から、バニリルアルキルエーテル1質量部に対して原料乾燥物換算量で16〜10000質量部(ショウガ及びニンジンを含む場合は、その総量。以下、同じ)であることが好ましく、より好ましくはバニリルアルキルエーテル1質量部に対して原料乾燥物換算量で16〜8000質量部、さらに好ましくは16〜7500質量部である。ここで「原料乾燥物換算量」とは、抽出物を得るために必要な原料の乾燥重量を指す。以下でも「原料乾燥物換算量」をこの意味で用いる。 The content of the component (b) is not particularly limited, but from the viewpoint of improving the flavor of the vanillyl alkyl ether, 16 to 10,000 parts by mass (equivalent to ginger and carrot) as 1 mass part of the vanillyl alkyl ether in terms of the dry material. When it is contained, the total amount is the same, hereinafter the same), more preferably 16 to 8000 parts by mass, more preferably 16 to 7500 parts by mass in terms of a raw material dry matter relative to 1 part by mass of vanillyl alkyl ether. It is. Here, “raw material dry matter amount” refers to the dry weight of the raw material necessary to obtain the extract. In the following, “raw material dry matter amount” is used in this sense.
本発明における生姜(ショウガ、ショウキョウ)は、ショウガ科のショウガZingiber officinale(ジンジバル オフィシナル)の根茎である。本発明における生姜の含有量は、特に限定されないが、好ましくは、バニリルアルキルエーテル1質量部に対して生姜乾燥物換算量で16〜2500質量部である。 The ginger (ginger, ginger) in the present invention is a rhizome of ginger Zingiber officinale (Zingival officinal) of the ginger family. The content of ginger in the present invention is not particularly limited, but is preferably 16 to 2500 parts by mass in terms of dry ginger with respect to 1 part by mass of vanillyl alkyl ether.
本発明における人参(ニンジン)は、本品はオタネニンジンPanax ginseng C. A. Meyer(Panax schinseng Nees) (Araliaceae)の細根を除いた根又はこれを軽く湯通ししたものである。本発明における人参の含有量は、特に限定されないが、好ましくは、バニリルアルキルエーテル1質量部に対して人参乾燥物換算量で100〜7500質量部である。 The ginseng (carrot) in the present invention is obtained by removing the fine roots of Panax ginseng C. A. Meyer (Panax schinseng Nees) (Araliaceae) or lightly blanched the carrot. The content of ginseng in the present invention is not particularly limited, but is preferably 100 to 7500 parts by mass of dry ginseng per 1 part by mass of vanillyl alkyl ether.
本発明におけるビタミンB1若しくはその誘導体又はその塩は、通常可食性のものを指し、具体的にはチアミン、塩酸チアミン、硝酸チアミンなどをあげることができる。特に硝酸チアミンが好ましい。本発明におけるビタミンB1若しくはその誘導体又はその塩の含有量は、特に限定されないが、風味改善の面から、バニリルアルキルエーテル1質量部に対して0.1〜30質量部であることが好ましく、より好ましくは、バニリルアルキルエーテル1質量部に対して0.16〜25質量部である。 The vitamin B1 or a derivative thereof or a salt thereof in the present invention usually indicates an edible substance, and specific examples thereof include thiamine, thiamine hydrochloride, and thiamine nitrate. Particularly, thiamine nitrate is preferable. The content of vitamin B1 or a derivative thereof or a salt thereof in the present invention is not particularly limited, but is preferably 0.1 to 30 parts by mass relative to 1 part by mass of vanillyl alkyl ether from the viewpoint of improving flavor. More preferably, the amount is 0.16 to 25 parts by mass with respect to 1 part by mass of the vanillyl alkyl ether.
本発明におけるビタミンB2若しくはその誘導体又はその塩とは、通常可食性のものを指し、具体的にはリボフラビン、リン酸リボフラビン、酪酸リボフラビン、フラビンアデニンヌクレオチド及びそれらの塩などをあげることができる。特にリン酸リボフラビンが好ましい。本発明におけるビタミンB2若しくはその誘導体又はその塩の含有量は、特に限定されないが、風味改善の面から、バニリルアルキルエーテル1質量部に対して0.1〜50質量部であることが好ましく、より好ましくは、バニリルアルキルエーテル1質量部に対して0.3〜30質量部である。 In the present invention, vitamin B2 or a derivative thereof or a salt thereof usually refers to an edible substance, and specific examples include riboflavin, riboflavin phosphate, riboflavin butyrate, flavin adenine nucleotide and salts thereof. Particularly, riboflavin phosphate is preferred. The content of vitamin B2 or a derivative thereof or a salt thereof in the present invention is not particularly limited, but is preferably 0.1 to 50 parts by mass relative to 1 part by mass of vanillyl alkyl ether from the viewpoint of improving flavor. More preferably, the amount is 0.3 to 30 parts by mass relative to 1 part by mass of the vanillyl alkyl ether.
本発明に用いるポリオキシエチレン硬化ヒマシ油とは、ヒマシ油に水素を添加して得た硬化油に、酸化エチレンを付加重合させて得た非イオン性界面活性剤で、酸化エチレンの平均付加モル数は、約30〜120のポリオキシエチレン硬化ヒマシ油であり、可溶化力や風味の点から、特に酸化エチレンの平均付加モル数は約60が好ましい。本発明におけるポリオキシエチレン硬化ヒマシ油の含有量は、特に限定されないが、風味改善の面から、バニリルアルキルエーテル1質量部に対して8〜3500質量部であることが好ましく、より好ましくはバニリルアルキルエーテル1質量部に対して8〜3000質量部である。 Polyoxyethylene hydrogenated castor oil used in the present invention is a nonionic surfactant obtained by addition polymerization of ethylene oxide to a hydrogenated oil obtained by adding hydrogen to castor oil. The number is about 30 to 120 polyoxyethylene hydrogenated castor oil, and from the viewpoint of solubilizing power and flavor, the average addition mole number of ethylene oxide is particularly preferably about 60. The content of the polyoxyethylene hydrogenated castor oil in the present invention is not particularly limited, but is preferably from 8 to 3500 parts by mass, more preferably from 1 to 3 parts by mass, more preferably from the viewpoint of improving flavor. The amount is 8 to 3000 parts by mass relative to 1 part by mass of the alkylalkyl ether.
本発明に用いるポリグリセリン脂肪酸エステルとは、脂肪酸とポリグリセリンのエステルである。ポリグリセリン脂肪酸エステルとしては、例えば、デカグリセリンモノミリスチン酸エステル、ヘキサグリセリンモノミリスチン酸エステル、デカグリセリンモノラウリン酸エステル、ヘキサグリセリンモノラウリン酸エステル、デカグリセリンモノステアリン酸エステル、ヘキサグリセリンモノステアリン酸エステル、デカグリセンモノカプリル酸エステル、デカグリセリンモノオレイン酸エステル、ヘキサグリセリンモノオレイン酸エステル、デカグリセリンモノリノレン酸エステル等が挙げられる。これらの中でも、可溶化力や風味の点から、デカグリセリンモノミリスチン酸エステル、デカグリセリンモノステアリン酸エステルおよびデカグリセリンモノオレイン酸エステルが好ましい。これらポリグリセリン脂肪酸エステルは、1種だけでなく、2種以上を配合してもよい。本発明におけるポリグリセリン脂肪酸エステルの含有量は、特に限定されないが、風味改善の面から、バニリルアルキルエーテル1質量部に対して8〜3500質量部であることが好ましく、より好ましくはバニリルアルキルエーテル1質量部に対して10〜300質量部である。 The polyglycerin fatty acid ester used in the present invention is an ester of a fatty acid and polyglycerin. Examples of polyglycerin fatty acid esters include, for example, decaglycerin monomyristate, hexaglycerin monomyristate, decaglycerin monolaurate, hexaglycerin monolaurate, decaglycerin monostearate, hexaglycerin monostearate, decaglycerol Glycene monocaprylate, decaglycerin monooleate, hexaglycerin monooleate, decaglycerin monolinolenate, and the like. Among these, decaglycerin monomyristate, decaglycerin monostearate and decaglycerin monooleate are preferred from the viewpoint of solubilizing power and flavor. These polyglycerin fatty acid esters may be used alone or in combination of two or more. The content of the polyglycerin fatty acid ester in the present invention is not particularly limited, but is preferably 8 to 3500 parts by mass, more preferably vanillyl alkyl, per 1 part by mass of vanillyl alkyl ether from the viewpoint of improving flavor. It is 10 to 300 parts by mass with respect to 1 part by mass of ether.
本発明にかかる飲用組成物のpHは、特に限定されず、例えば、2.0〜7.0である。風味の観点からは低pHであることが好ましく、さらに好ましくは2.5〜5.5である。本発明の飲用組成物のpH調整は、通常使用されるpH調整剤を使用することができる。具体的なpH調整剤としては、クエン酸、リンゴ酸、酒石酸、コハク酸、乳酸、酢酸、マレイン酸、グルコン酸、アスパラギン酸、アジピン酸、グルタミン酸、フマル酸等の有機酸及びそれらの塩類、塩酸等の無機酸、水酸化ナトリウムなどの無機塩基等が挙げられる。 The pH of the drinking composition according to the present invention is not particularly limited, and is, for example, 2.0 to 7.0. From the viewpoint of flavor, the pH is preferably low, and more preferably 2.5 to 5.5. For adjusting the pH of the drinking composition of the present invention, a commonly used pH adjuster can be used. Specific pH adjusters include citric acid, malic acid, tartaric acid, succinic acid, lactic acid, acetic acid, maleic acid, gluconic acid, aspartic acid, adipic acid, glutamic acid, organic acids such as fumaric acid and salts thereof, hydrochloric acid And inorganic bases such as sodium hydroxide.
本発明の飲用組成物にはその他の成分として、他のビタミン類、ミネラル類、アミノ酸及びその塩類、他の生薬や生薬抽出物などを本発明の効果を損なわない範囲で適宜に配合することができる。 In the drinking composition of the present invention, as other components, other vitamins, minerals, amino acids and salts thereof, other crude drugs and crude drug extracts and the like may be appropriately blended as long as the effects of the present invention are not impaired. it can.
さらに必要に応じて、甘味料、酸味料、増粘安定剤、酸化防止剤、着色剤、香料、矯味剤、保存料、調味料、苦味料、強化剤、可溶化剤、乳化剤などの添加物を本発明の効果を損なわない範囲で適宜に配合することができる。 If necessary, additives such as sweeteners, acidulants, thickening stabilizers, antioxidants, coloring agents, flavors, corrigents, preservatives, seasonings, bitters, enhancers, solubilizers, emulsifiers, etc. Can be appropriately compounded within a range that does not impair the effects of the present invention.
本発明の飲用組成物は、常法により調製することができ、その方法は特に限定されるものではない。通常、各成分をとり適量の精製水で溶解した後、pHを調整し、残りの精製水を加えて容量調製し、必要に応じてろ過、殺菌処理し、容器に充填する工程により製造することができる。 The drinking composition of the present invention can be prepared by a conventional method, and the method is not particularly limited. Usually, after taking each component and dissolving with an appropriate amount of purified water, adjust the pH, adjust the volume by adding the remaining purified water, filter and sterilize as needed, and manufacture by filling in containers. Can be.
本発明の飲用組成物は、例えばシロップ剤、ドリンク剤などの医薬品や医薬部外品などの各種製剤、健康飲料、清涼飲料などの各種飲料に適用することができる。 The drinking composition of the present invention can be applied to various preparations such as pharmaceuticals such as syrups and drinks and quasi-drugs, and various drinks such as health drinks and soft drinks.
以下に実施例、比較例及び試験例を挙げ、本発明をさらに詳しく説明するが、本発明はこれらの実施例等に何ら限定されるものではない。
(実施例A1〜B22、比較例A1〜B11)
専門パネル5名により、表1に従って、表2〜9に示す組成の飲料について、バニリルアルキルエーテル由来の不快味(辛味)を評価した。
バニリルアルキルエーテル由来の不快味がどのように感じられるかについて、事前にパネル間で意見交換し、辛味・苦さ・雑味が特徴的であると認定した。本実施例においては、前記辛味・苦さ・雑味のなかで最も不快味として強く感じられる辛味を評価した。
評価結果は、専門パネル5名のスコアの平均値で表し、表2〜9に示した。
Hereinafter, the present invention will be described in more detail with reference to Examples, Comparative Examples, and Test Examples, but the present invention is not limited to these Examples and the like.
(Examples A1 to B22, Comparative Examples A1 to B11)
Five expert panels evaluated the beverages having the compositions shown in Tables 2 to 9 for the unpleasant taste (pungency) derived from vanillyl alkyl ether according to Table 1.
Panels exchanged opinions in advance about how unpleasant taste derived from vanillyl alkyl ether was felt, and found that pungency, bitterness, and aroma were characteristic. In this example, the pungency which was strongly felt as the most unpleasant among the pungent, bitter, and unpleasant tastes was evaluated.
The evaluation results were represented by the average value of the scores of five specialized panels, and are shown in Tables 2 to 9.
表2では、比較例A1を基準とし比較例A2及びA3を評価し、実施例A1〜A3は比較例A2を基準とし、実施例A4〜A5は比較例A3を基準として評価した。 In Table 2, Comparative Examples A2 and A3 were evaluated based on Comparative Example A1, and Examples A1 to A3 were evaluated based on Comparative Example A2, and Examples A4 to A5 were evaluated based on Comparative Example A3.
表3では、比較例A4を基準とし比較例A5及びA6を評価し、実施例A6〜A9は比較例A5を基準とし、実施例A10〜A12は比較例A6を基準として評価した。 In Table 3, Comparative Examples A5 and A6 were evaluated based on Comparative Example A4. Examples A6 to A9 were evaluated based on Comparative Example A5, and Examples A10 to A12 were evaluated based on Comparative Example A6.
表4では、比較例A1を基準とし比較例A7及びA8を評価し、実施例A13〜A14は比較例A7を基準とし、実施例A15〜A19は比較例A8を基準として評価した。 In Table 4, Comparative Examples A7 and A8 were evaluated on the basis of Comparative Example A1, Examples A13 to A14 were evaluated on the basis of Comparative Example A7, and Examples A15 to A19 were evaluated on the basis of Comparative Example A8.
表5では、比較例A4を基準とし比較例A9及びA10を評価し、実施例A20〜A24は比較例A9を基準とし、実施例A25〜A26は比較例A10を基準として評価した。 In Table 5, Comparative Examples A9 and A10 were evaluated based on Comparative Example A4, and Examples A20 to A24 were evaluated based on Comparative Example A9, and Examples A25 to A26 were evaluated based on Comparative Example A10.
表6では、比較例B1を基準とし比較例B2及びB3を評価し、実施例B1〜B3は比較例B2を基準とし、実施例B4〜B6は比較例B3を基準として評価した。 In Table 6, Comparative Examples B2 and B3 were evaluated based on Comparative Example B1, and Examples B1 to B3 were evaluated based on Comparative Example B2, and Examples B4 to B6 were evaluated based on Comparative Example B3.
表7では、比較例B4を基準とし比較例B5及びB6を評価し、実施例B7〜B11は比較例B5を基準とし、実施例B12〜B13は比較例B6を基準として評価した。 In Table 7, Comparative Examples B5 and B6 were evaluated based on Comparative Example B4, and Examples B7 to B11 were evaluated based on Comparative Example B5, and Examples B12 and B13 were evaluated based on Comparative Example B6.
表8では、比較例B7を基準とし比較例B8及びB9を評価し、実施例B14は比較例B8を基準とし、実施例B15〜B16は比較例B9を基準として評価した。 In Table 8, Comparative Examples B8 and B9 were evaluated based on Comparative Example B7, Example B14 was evaluated based on Comparative Example B8, and Examples B15 and B16 were evaluated based on Comparative Example B9.
表9では、比較例B10を基準とし比較例B11を評価し、実施例B17〜B22は比較例B11を基準として評価した。 In Table 9, Comparative Example B11 was evaluated based on Comparative Example B10, and Examples B17 to B22 were evaluated based on Comparative Example B11.
表2〜9から明らかなように、ショウキョウ又はニンジン存在下ではバニリルエチルエーテル又はバニリルブチルエーテルの不快味が増強されていた。しかし、ビタミンB1、ビタミンB2、ポリオキシエチレン硬化ヒマシ油存在下では実施例A1〜A3は比較例A2と比較してバニリルエチルエーテル又はバニリルブチルエーテルの不快味が改善されていた。この結果からビタミンB1、ビタミンB2及びポリオキシエチレン硬化ヒマシ油から選ばれる1種以上を含有させることにより、バニリルエチルエーテル又はバニリルブチルエーテルが含有された際に生じる不快味を改善できることが明らかとなった。 As is clear from Tables 2 to 9, the unpleasant taste of vanillyl ethyl ether or vanillyl butyl ether was enhanced in the presence of ginger or carrot. However, in the presence of vitamin B1, vitamin B2, and polyoxyethylene hydrogenated castor oil, Examples A1 to A3 had improved unpleasant taste of vanillyl ethyl ether or vanillyl butyl ether as compared with Comparative Example A2. From these results, it is clear that by containing at least one selected from vitamin B1, vitamin B2 and polyoxyethylene hydrogenated castor oil, the unpleasant taste generated when vanillyl ethyl ether or vanillyl butyl ether is contained can be improved. became.
(実施例C1〜C12、比較例C1〜C3)
表2〜9と同様に、表10〜11に示す組成の飲料について、バニリルアルキルエーテル由来の不快味(辛味)を評価し、結果を表10〜11に示した。
(Examples C1 to C12, Comparative Examples C1 to C3)
Similarly to Tables 2 to 9, the beverages having the compositions shown in Tables 10 to 11 were evaluated for unpleasant taste (pungency) derived from vanillyl alkyl ether, and the results are shown in Tables 10 to 11.
表10では、比較例C1を基準とし比較例C2を評価し、実施例C1〜C6は比較例C2を基準として評価した。 In Table 10, Comparative Example C2 was evaluated based on Comparative Example C1, and Examples C1 to C6 were evaluated based on Comparative Example C2.
表11では、比較例C1を基準とし比較例C3を評価し、実施例C7〜C12は比較例C3を基準として評価した。 In Table 11, Comparative Example C3 was evaluated based on Comparative Example C1, and Examples C7 to C12 were evaluated based on Comparative Example C3.
表10〜11から明らかなように、ショウキョウ又はニンジン存在下ではバニリルアルキルエーテルの不快味が増強されたが、ビタミンB1、ビタミンB2、ポリオキシエチレン硬化ヒマシ油存在下では、不快味が改善された。さらに、ビタミンB1、ビタミンB2、ポリオキシエチレン硬化ヒマシ油、複数成分を含有させることで、不快味改善効果が高まった。 As is clear from Tables 10 to 11, the unpleasant taste of vanillyl alkyl ether was enhanced in the presence of ginger or carrot, but was improved in the presence of vitamin B1, vitamin B2, and polyoxyethylene hydrogenated castor oil. Was done. Furthermore, by containing vitamin B1, vitamin B2, polyoxyethylene hydrogenated castor oil and a plurality of components, the effect of improving the unpleasant taste was enhanced.
(実施例D1〜D5、比較例D1〜D3)
表2〜11と同様に、表12〜13に示す組成の飲料について、バニリルアルキルエーテル由来の不快味(辛味)を評価し、結果を表12〜13に示した。
(Examples D1 to D5, Comparative Examples D1 to D3)
Similarly to Tables 2 to 11, the beverages having the compositions shown in Tables 12 and 13 were evaluated for unpleasant taste (pungency) derived from vanillyl alkyl ether, and the results are shown in Tables 12 and 13.
表12では、比較例D1を基準とし比較例D2を評価し、実施例D1〜D2は比較例D2を基準として評価した。 In Table 12, Comparative Example D2 was evaluated based on Comparative Example D1, and Examples D1 and D2 were evaluated based on Comparative Example D2.
表13では、比較例D1を基準とし比較例D3を評価し、実施例D3〜D5は比較例D3を基準として評価した。 In Table 13, Comparative Example D3 was evaluated based on Comparative Example D1, and Examples D3 to D5 were evaluated based on Comparative Example D3.
表12〜13から明らかなように、ショウキョウ又はニンジン存在下ではバニリルアルキルエーテルの不快味が増強されたが、ポリグリセリン脂肪酸エステル存在下では、不快味が改善された。 As is clear from Tables 12 and 13, the unpleasant taste of vanillyl alkyl ether was enhanced in the presence of ginger or carrot, but was improved in the presence of polyglycerin fatty acid ester.
本発明によりバニリルエチルエーテル、及び/又はバニリルブチルエーテルの風味が改善された内服液剤を得ることができ、医薬品、食品、健康飲料、特定保健用食品などに使用可能である。 INDUSTRIAL APPLICABILITY According to the present invention, an oral solution having an improved flavor of vanillyl ethyl ether and / or vanillyl butyl ether can be obtained, and can be used for medicines, foods, health drinks, foods for specified health uses, and the like.
Claims (6)
b)生姜又は人参から選ばれる少なくとも1種、及び
c)ビタミンB1若しくはその誘導体又はその塩、ビタミンB2若しくはその誘導体又はその塩、ポリオキシエチレン硬化ヒマシ油、及びポリグリセリン脂肪酸エステルからなる群より選ばれる少なくとも1種
を含有する飲用組成物。 a) at least one kind of vanillyl alkyl ether selected from vanillyl ethyl ether or vanillyl butyl ether; b) at least one kind selected from ginger or ginseng; and c) vitamin B1 or a derivative thereof or a salt thereof, vitamin B2 or a derivative thereof. Or a salt thereof, a polyoxyethylene hydrogenated castor oil, and a drinking composition comprising at least one selected from the group consisting of polyglycerin fatty acid esters.
b)生姜又は人参から選ばれる少なくとも1種が原料乾燥物換算量で16〜10000質量部であることを特徴とする請求項1に記載の飲用組成物。 a) For 1 part by mass of vanillyl alkyl ether,
b) The drinking composition according to claim 1, wherein at least one selected from ginger and ginseng is 16 to 10000 parts by mass in terms of a raw material dry matter.
c)ビタミンB1若しくはその誘導体又はその塩が0.1〜30質量部であることを特徴とする請求項1に記載の飲用組成物。 a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) vitamin B1, a derivative thereof, or a salt thereof is 0.1 to 30 parts by mass.
c)ビタミンB2若しくはその誘導体又はその塩が0.1〜50質量部であることを特徴とする請求項1に記載の飲用組成物。 a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) vitamin B2 or a derivative thereof or a salt thereof is 0.1 to 50 parts by mass.
c)ポリオキシエチレン硬化ヒマシ油が8〜3500質量部であることを特徴とする請求項1に記載の飲用組成物。 a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) polyoxyethylene hydrogenated castor oil is 8 to 3500 parts by mass.
c)ポリグリセリン脂肪酸エステルが8〜3500質量部であることを特徴とする請求項1に記載の飲用組成物。 a) For 1 part by mass of vanillyl alkyl ether,
The drinking composition according to claim 1, wherein c) the polyglycerin fatty acid ester is 8 to 3500 parts by mass.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018148285 | 2018-08-07 | ||
JP2018148285 | 2018-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020022446A true JP2020022446A (en) | 2020-02-13 |
JP7489017B2 JP7489017B2 (en) | 2024-05-23 |
Family
ID=69617873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019139513A Active JP7489017B2 (en) | 2018-08-07 | 2019-07-30 | Drinking Composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7489017B2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012046477A (en) * | 2010-07-30 | 2012-03-08 | Takasago Internatl Corp | Agent and composition for mental exaltation |
US20130287871A1 (en) * | 2011-01-06 | 2013-10-31 | Johannes Coy | Refreshing beverage |
-
2019
- 2019-07-30 JP JP2019139513A patent/JP7489017B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012046477A (en) * | 2010-07-30 | 2012-03-08 | Takasago Internatl Corp | Agent and composition for mental exaltation |
US20130287871A1 (en) * | 2011-01-06 | 2013-10-31 | Johannes Coy | Refreshing beverage |
Non-Patent Citations (5)
Title |
---|
"食品番号:06103 食品群名/食品名:野菜類/(しょうが類)/しょうが/根茎、生", 食品成分表2014年版 資料編, JPN7023002531, 2014, JP, ISSN: 0005097938 * |
COLD-PRESSED DAILY PROBIOTIC ORGANIC MANGO CHAI FRUIT JUICE SMOOTHIE,MINTEL GNPD, [ONLINE], ID#5527, JPN7023002528, ISSN: 0005097936 * |
JI-SANG KIM: "Investigation of Phenolic, Flavonoid, and Vitamin Contents in Different Parts of Korean Ginseng (Pan", PREVENTIVE NUTRITION AND FOOD SCIENCE, vol. 21, no. 3, JPN7023002530, 30 September 2016 (2016-09-30), KR, pages 263 - 270, XP053036153, ISSN: 0005097939 * |
VANILLA BLISS MEAL REPLACEMENT SHAKE,MINTEL GNPD, [ONLINE], ID#2494873, 2014年06月, JPN7023002529, ISSN: 0005097937 * |
シリーズ累計30万本突破!爆発的人気クレンジングの姉妹品登場!マツエクしてても大丈夫!美容液成分で落, JPN6023027226, 2 February 2015 (2015-02-02), ISSN: 0005097940 * |
Also Published As
Publication number | Publication date |
---|---|
JP7489017B2 (en) | 2024-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2567175C2 (en) | Usage of rubozozid for attenuation or suppression of certain unpleasant taste sensations | |
JP5872187B2 (en) | Salt enhancer | |
JP5019659B1 (en) | Bitterness / Astringency Inhibitor | |
JP6508671B2 (en) | Composition comprising red pepper extract and / or ginger extract, and method for producing the same | |
JP6866598B2 (en) | Beverage | |
KR101771811B1 (en) | Taste-improving agent for highly intensity sweetener comprising an extract of japanese pepper | |
JP6519248B2 (en) | Crude drug extract-containing beverage | |
JP5543655B1 (en) | Beverages that stably contain useful ingredients in turmeric | |
JP7489017B2 (en) | Drinking Composition | |
KR100886145B1 (en) | Method for Debitterizing Ginseng or Red Ginseng Products | |
JP6760710B2 (en) | Beverage | |
JP6307816B2 (en) | Beverage | |
JP6152251B2 (en) | Spring turmeric component-containing beverage and method for adjusting flavor with spring turmeric component | |
JP6284136B1 (en) | Bitter taste inhibitor | |
JP7489018B2 (en) | Drinking Composition | |
JP7080880B2 (en) | candy | |
KR20160026665A (en) | Flavor composition and method for enhancing flavoring taste | |
JP5543652B1 (en) | Method for producing a beverage containing useful ingredients in turmeric | |
JP2015171328A (en) | acidic seasoning | |
WO2021235481A1 (en) | Taste improving composition | |
JPWO2013140973A1 (en) | Beverage | |
JP7191890B2 (en) | Astringent taste enhancer for food and drink containing rotandone as an active ingredient | |
JP6350157B2 (en) | Internal liquid | |
JP6261263B2 (en) | Turmeric extract-containing beverage | |
JP6300154B2 (en) | Beverage containing star anise extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220714 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230616 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230704 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230824 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230926 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231128 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240111 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20240308 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240411 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240424 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7489017 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |